药物对比
Chlorpropamide vs Ertugliflozin
Chlorpropamide vs Ertugliflozin：较老的磺酰脲类 vs SGLT2抑制剂，用于2型糖尿病。低血糖风险较高 vs 减重、心血管获益。比较副作用与适用性。
此页面暂无可用的对比维度。
临床背景
This comparison typically occurs when reviewing legacy first-generation sulfonylureas against modern SGLT2 inhibitors for type 2 diabetes.
结论
Ertugliflozin is preferred over Chlorpropamide for most patients based on safety and extra benefits, but therapy must be individualized.
全部药物对比